All > Microbiome

Pediasure for Critical Illness

Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA
Critical Illness+2 More ConditionsNourish - Other
Eligibility
1 - 17
All Sexes
What conditions do you have?
Select

Study Summary

This trial will study whether two different types of formula have different effects on the gut microbiome of critically ill children.

Eligible Conditions
  • Critical Illness
  • Imbalance of Microbes
  • Acute Lymphoblastic Leukemia (ALL) in Children.

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
Guanfacine
2
Post-Implementation Targeting Normoxemia in Burn ICU
2
Targeting Normoxia (SpO2 90-96%; PaO2 60-100 mmHg)

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: Prior to initiation of enteral tube feeds then on day 1, day 5-7, and day 14 of feedings

Day 14
Changes to the gastrointestinal microbiome
Concentration of short-chain fatty acids

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

2
Guanfacine
3
Post-Implementation Targeting Normoxemia in Burn ICU
3
Targeting Normoxia (SpO2 90-96%; PaO2 60-100 mmHg)

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Pediasure
1 of 2
Nourish
1 of 2

Active Control

40 Total Participants · 2 Treatment Groups

Primary Treatment: Pediasure · No Placebo Group · N/A

Pediasure
Other
ActiveComparator Group · 1 Intervention: Pediasure · Intervention Types: Other
Nourish
Other
ActiveComparator Group · 1 Intervention: Nourish · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: prior to initiation of enteral tube feeds then on day 1, day 5-7, and day 14 of feedings

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,646 Previous Clinical Trials
16,311,467 Total Patients Enrolled
13 Trials studying Critical Illness
5,037 Patients Enrolled for Critical Illness
Raj Aneja, MDPrincipal InvestigatorUniversity of Pittsburgh Medical Center

Eligibility Criteria

Age 1 - 17 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have had a feeding tube placed in your digestive system before.
References

Frequently Asked Questions

Is this research initiative currently accepting individuals for participation?

"The clinical trial is currently accepting participants, according to details available on clinicialtrials.gov. Originally posted on February 2nd 2018, the study was last updated September 19th 2022." - Anonymous Online Contributor

Unverified Answer

How many individuals are being admitted to the trial's cohort?

"Affirmative. According to the information hosted on clinicaltrials.gov, this clinical trial is currently recruiting participants and was initially posted on February 2nd 2018. Up until September 19th 2022, 40 individuals from 1 location have been accepted into the study." - Anonymous Online Contributor

Unverified Answer

What criteria must be met to qualify as a participant in this research study?

"To be eligible for inclusion in this clinical study, potential participants must have a severe illness and fall between 1 year old and 17 years old. The aim of the trial is to recruit 40 patients." - Anonymous Online Contributor

Unverified Answer

Does the research allow for geriatric populations to join?

"This clinical trial requires participants to be aged 1 year up to 17 years. Out of the 221 different trials, 49 are specific for those below 18 and 172 target patients over 65." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top